The Smith & Nephew Birmingham Hip Resurfacing (BHR) hip implant system (approved in 2006), is commonly used by surgeons who want to preserve the patient’s femoral head. However, the BHR system has been found to create problems in patients who do not meet a very limited list of qualifications.
In Smith & Nephew’s 2015 BHR recall, officials issued a safety notice stating that patients over 65 and patients that required an implant head 48 mm or smaller experienced an increased risk of needing revision surgery. The also stated that the BHR implants created a risk for fractures, dislocation, and an assortment of other complications that could lead to revision surgery.
But the safety notice didn’t stop at that release. Shortly later, they released yet another notice advising surgeons to not implant the BHR in female patients and to not use BHR femoral head components less than 46 mm in size. According to sources, the BHR has a 26% failure rate in women after ten years. Additionally, patients who experienced injuries from a faulty BHR complained
of severe and persistent pain.